Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2022-09-07 00:00:00 ET · period of report 2022-09-02 · accession 0001062993-22-019274 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-07 | 2022-09-02 | BIO | Daskal Ilan | EVP, CFO | M - OptEx | $0.00 | +541 | 1,222 | +79% | $0 |
| D | 2022-09-07 | 2022-09-02 | BIO | Daskal Ilan | EVP, CFO | F - Tax | $478.32 | -269 | 953 | -22% | -$128.7K |
| D | 2022-09-07 | 2022-09-02 | BIO | Daskal Ilan | EVP, CFO | M - OptEx | $0.00 | -541 | 1,084 | -33% | $0 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2022-09-02 | M | A | 541 | $0.00 | 1,222 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2022-09-02 | F | D | 269 | $478.32 | 953 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-09-02 | M | D | 541 | $0.00 | 1,084 | D | $0.00 · — to — | 541 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |